Racura Oncology LtdASX: RAC

Racura Presents Bisantrene MYC Data at FCS 2026

· Issued by Racura Oncology Ltd via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Racura Oncology Ltd has announced the presentation of new preclinical data on (E,E)-bisantrene at the Frontiers in Cancer Science Conference in Singapore. The data indicate that (E,E)-bisantrene stabilizes the MYC G-quadruplex structure, leading to reduced MYC gene expression and activity.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/racura-presents-bisantrene-myc-data-at-fcs-2026-1

Release

ASX Announcement Racura Presents Bisantrene MYC Data at FCS 2026 Conference § Racura presenting at the Frontiers in Cancer Science (FCS) 2026 Conference being held in Singapore from 11–13 November 2026 § Preclinical data presented show that (E,E)-bisantrene is the active isomer stabilising the...

Racura Oncology Ltd on 6ix

Earlier from Racura Oncology

All Racura Oncology news releases